Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCFD2 antisense RNA 1 (SCFD2-AS1) is a long non-coding RNA (lncRNA), classified specifically as an antisense RNA, which is transcribed from the DNA strand opposite to the SCFD2 gene. Antisense RNAs are regulatory single-stranded RNAs that can hybridize to target messenger RNAs (mRNAs) or interact with epigenetic machinery, thereby modulating gene expression at various stages including transcription, RNA processing, and translation. SCFD2-AS1’s precise biological or clinical role is not well-characterized in available literature; no specific functions, disease associations, or drug interactions have been described for this lncRNA to date. Its classification as a non-coding antisense RNA suggests its main role is likely the regulation of SCFD2 expression, potentially in a tissue-, development-, or disease-specific manner, akin to other antisense lncRNAs. There is no evidence that SCFD2-AS1 serves as a direct therapeutic target, biomarker, or interacts with any drugs presently.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SCFD2 antisense RNA 1 (SCFD2-AS1).